Researchers at Texas A&M Health have identified a molecular mechanism that increases cholesterol levels inside prostate cancer cells—an important process that may help explain how some tumors progress ...

A study found microplastics in prostate tumors, with higher levels in cancer tissue, prompting further research into ...

Several experimental prostate cancer drugs have produced striking results in early-stage clinical trials, with at least one ...

Prostate cancer is one of the most common cancers and the second leading cause of cancer-related death in men worldwide. However, the mechanisms controlling the early stages of prostate cancer ...

Microplastics were detected in prostate tissue from nearly all patients undergoing prostate cancer surgery in a small proof-of-concept study presented at the American Society of Clinical Oncology ...

Abstract Highlights Rinzimetostat is a potent and highly selective next-generation allosteric PRC2 inhibitor targeting the EED subunit that has demonstrated potential best-in-class efficacy and safety ...

Prostate cancer is one of the most common malignant tumors in men, ranking second in global male cancer incidence and first in Europe and North America. Although therapies targeting androgen and the ...

The Prostate Cancer Foundation (PCF) today announced the launch of the Hästens-PCF Global Health Award, a new initiative designed to advance equitable prostate cancer detection, diagnosis, and care in ...